OpenAlex
PricingAboutJobs
Log inGet started
Work

Baseline characteristics of the patient population in the Saxagliptin Assessment of Vascular Outcomes Recorded in patients with diabetes mellitus (SAVOR)‐TIMI 53 trial

HTML

Year: 2013
Type: article
Source: Diabetes/Metabolism Research and Reviews
DOI: 10.1002/dmrr.2413
Authors: O. Mosenzon, I. Raz, B. M. Scirica, B. Hirshberg, C. I. Stahre, P. G. Steg, J. Davidson, P. Ohman, D. L. Price, B. Frederich, J. A. Udell, E. Braunwald, D. L. Bhatt
Institutions: Hadassah Medical Center, Brigham and Women's Hospital, Harvard University, Thrombolysis in Myocardial Infarction Study Group, AstraZeneca (United States), AstraZeneca (Sweden), Inserm, Sorbonne Paris Cité, Université Paris Diderot, The University of Texas Southwestern Medical Center, Bristol-Myers Squibb (United States), VA Boston Healthcare System
Language: English

Topic: Diabetes Treatment and Management
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Keywords: saxagliptin, SAVOR-TIMI 53, type 2 diabetes, DPP-4 inhibitors, cardiovascular outcomes, baseline characteristics, HbA1c, diabetes treatment, insulin use, statin use, diabetes complications, diabetic nephropathy, diabetic retinopathy, microalbuminuria, inflammatory markers, insulin resistance, regional variation
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W1494561942
FWCI: 5.187
Cites: 51
Cited by: 52
Related to: 9
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security